- Nearly one health care company board member in every 10 also serves as a top academic from a renowned medical and research institution.
- A new study confirms the link between everyday drugs, those medications with anticholinergic effects, and dementia.
- A drug designed to inhibit inflammatory proteins may help obese and overweight people lose weight.
- With a high cost and only marginal benefits, the new weight loss drug may not be helpful to a majority of people.
- A new study estimates 'evergreen' policies that extend the life of drug patents substantially increased health care costs in Geneva.
FDA Approves Two Next-Gen Melanoma Drugs From GlaxoSmithKline; More Hope For Advanced Cancer PatientsGSK's new melanoma drugs are targeted toward specific mutations present in the skin cancer.
- Liraglutide (Victoza), currently approved to treat type 2 diabetes, will be re-branded and sold as a weight-loss aid.
- Already approved for breast cancer treatment, ABRAXANE has shown promise in increasing survival of advanced pancreatic cancer patients.
- A promising sleeping pill, with fewer side effects than current drugs on the market, is in the midst of the FDA approval process.
- The new drug will soon be submitted to the FDA for approval to treat the blood cell proliferative disorder myelofibrosis.
- With stunning results in Phase III clinical trials, the hepatitis C drug is now on a fast track for FDA approval.
- A computer algorithm has mapped all the possible carbon-based structures in the ‘small molecule universe’ that might be created as drugs in pharmaceutical labs— even chemical compounds that don’t exist yet.